0001209191-21-027459.txt : 20210419 0001209191-21-027459.hdr.sgml : 20210419 20210419210016 ACCESSION NUMBER: 0001209191-21-027459 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210415 FILED AS OF DATE: 20210419 DATE AS OF CHANGE: 20210419 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chereau Frederic CENTRAL INDEX KEY: 0001640592 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38707 FILM NUMBER: 21836036 MAIL ADDRESS: STREET 1: C/O ATYR PHARMA, INC. STREET 2: 3545 JOHN HOPKINS COURT, SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LogicBio Therapeutics, Inc. CENTRAL INDEX KEY: 0001664106 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 471514975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 65 HAYDEN AVE STREET 2: 2ND FLOOR CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-245-0399 MAIL ADDRESS: STREET 1: 65 HAYDEN AVE STREET 2: 2ND FLOOR CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-04-15 0 0001664106 LogicBio Therapeutics, Inc. LOGC 0001640592 Chereau Frederic 65 HAYDEN AVENUE, FLOOR 2 LEXINGTON MA 02421 1 1 0 0 President and Chief Executive Common Stock 2021-04-15 4 M 0 23414 A 261353 D Common Stock 2021-04-16 4 S 0 7542 5.73 D 253811 D Restricted Stock Units 2021-04-15 4 M 0 23414 0.00 D Common Stock 23414 0 D Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock of LogicBio Therapeutics, Inc. (the "Company"). Relates to shares sold at a weighted average price of $5.73 per share to cover tax withholding obligations in connection with the vesting of RSUs. Shares were sold in multiple transactions at prices ranging from $5.64 to $5.87, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. All of the RSUs vested on April 15, 2021, subject to the terms and conditions of the award and the Company's 2018 Equity Incentive Plan. /s/ Frederic Chereau 2021-04-19